ALKERMES, INC. for ALKERMES, INC.

Law Enforcement/Crime/Criminal Justice LAW

Preserving access to medications for patients with Serious Mental Illness

Contacted: Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Natl Institutes of Health (NIH); SENATE; Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Substance Abuse & Mental Health Services Administration (SAMHSA)

Alcohol and Drug Abuse ALC

Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings HR 1329 - Medicaid Reentry Act S.1983, CREATE Opportunities Act, H.R. 3496 CREATE Opportunities Act H.R. 1158, FY20 Consolidated Appropriations Act (PL-116-93) H.R. 1865, FY20 Further Consolidated Appropriations Act (PL 116-94) H.R. 133, Consolidated Appropriations Act, 2021 (PL 116-260)

Contacted: Executive Office of the President (EOP); SENATE; Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); Veterans Affairs, Dept of (VA); Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Bills named: H.R. 1329 (116th), H.R. 3496 (116th), H.R. 1158 (116th), S. 1983 (116th), H.R. 133 (116th), H.R. 1865 (116th)

Health Issues HCR

Awareness of the need for treatment system reform and access to all FDA-approved medications Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments Awareness of outcomes data and the need for training on all medication assisted treatment Initiatives to promote the use of relapse prevention post detoxification SUPPORT for Patient and Communities Act (PL 115-271) S. 3312/HR 5909 - Crisis Stabilization and Community Reentry Act S. 2690, Restoring, Enhancing, Securing, and Promoting Our Nation's Safety Efforts Act of 2019

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE; Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); Veterans Affairs, Dept of (VA); Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA)

Bills named: S. 2690 (116th), S. 3312 (116th), H.R. 5909 (116th)

Medicare/Medicaid MMM

Maintain six protected classes for depressions and schizophrenia under Medicare Part D Drug pricing issues - HR3 - Lower Drug Costs Now Act; S2543 - Prescription Drug Pricing Reduction Act; H.R. 19 - Lower Costs, More Cures Act of 2019; H.R. 133 - Consolidated Appropriations Act, 2021 (PL 116-260) - Maintain Medicaid rebates for MAT products; SUPPORT Act (PL 115-271) - Maintain Medicaid rebates for MAT products;

Contacted: Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Natl Institutes of Health (NIH); Drug Enforcement Administration (DEA)

Bills named: H.R. 19 (116th), H.R. 3 (116th), H.R. 133 (116th)